Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mosanna Therapeutics logo — A Swiss Biotech company with a commitment to improving patie...

Mosanna Therapeutics

A Swiss Biotech company with a commitment to improving patient outcomes and quality of life in high unmet need diseases

Founded 2022 Switzerland Basel, Switzerland 7 employees Seed Biotechnology, Health and Wellness

General Information

Company Name Mosanna Therapeutics
Founded Year 2022
Location Switzerland Basel, Switzerland
Employees 7
Industries Biotechnology, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Mosanna Therapeutics. To contact Mosanna Therapeutics, visit mosanna.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Mosanna Therapeutics

Mosanna Therapeutics is a Swiss Biotech company with a strong commitment to improving patient outcomes and quality of life in high unmet need diseases through a precision medicine approach. Based in Basel, the company carefully selects innovative medicines for further development using top contract research organizations in their specialized field. Their primary focus is on bringing an effective and well-tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients. Established in 2022, Mosanna operates in the Biotechnology industry with its headquarters in Switzerland. The company recently received Seed Round investment on 11th April 2023 from prominent investors including High-Tech Gründerfonds, Forty51 Ventures, and Supermoon Capital. This injection of capital reflects the growing interest and confidence in Mosanna Therapeutics' innovative approach to addressing significant medical needs. With this support, the company is well-positioned to advance its development and potentially transform the treatment landscape for Metabolic Obstructive Sleep Apnea patients.

Taxonomy: Swiss Biotech, Basel, Precision Medicine, Patient Outcomes, Quality of Life, Unmet Need Diseases, Innovative Medicines, Contract Research Organisations, Metabolic Obstructive Sleep Apnea, Nasal Spray, Drug Development, Healthcare Innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 3
Forty51 Ventures Supermoon Capital
Forty51 Ventures, Supermoon Capital +1
11 Apr 2023
Seed Round Undisclosed 1
Forty51 Ventures
Forty51 Ventures
13 Jul 2022

Latest News

View All
From restless nights to better sleep: 10 European startups transforming how we rest, recover, and re... — Eu-startups
From restless nights to better sleep: 10 European startups transforming how we rest, recover, and recharge
Eu-startups Aug 21, 2025

Mosanna Therapeutics Alternatives & Competitors

Mosanna Therapeutics vs
Inspire Medical Systems
Inspire Medical Systems United States

We are committed to elevating and redefining the standard of care for Obstructive Sleep Apnea.

Post-IPO Equity
1195 employees
Biotechnology, Health Care
Mosanna Therapeutics vs
Pinteon Therapeutics
Pinteon Therapeutics

Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient outcomes in c...

Series B
2-10 employees
Biotechnology, Health Care
Mosanna Therapeutics vs
Iambic
Iambic United States

Better technology for better medicines

160 employees
AI, Biotechnology

FAQ About Mosanna Therapeutics

A Swiss Biotech company with a commitment to improving patient outcomes and quality of life in high unmet need diseases
Mosanna Therapeutics was founded in 2022.
Mosanna Therapeutics is headquartered in Basel, Switzerland.
Mosanna Therapeutics operates in Biotechnology and Health and Wellness. Its work centres on Swiss Biotech, Basel, Precision Medicine and Patient Outcomes.
Mosanna Therapeutics has approximately 7 employees.
Mosanna Therapeutics has completed 2 funding rounds. The latest funding stage is Seed.
Top alternatives and competitors to Mosanna Therapeutics include Inspire Medical Systems, Pinteon Therapeutics, Iambic, Certa Therapeutics, ImmunAbs Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mosanna Therapeutics and Inspire Medical Systems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Mosanna Therapeutics, https://bouncewatch.com/company/mosanna-therapeutics, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes